Article info
Original article
Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy
- Correspondence to Professor Makoto Saegusa, Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan; msaegusa{at}med.kitasato-u.ac.jp
Citation
Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy
Publication history
- Accepted January 3, 2012
- First published March 3, 2012.
Online issue publication
April 23, 2012
Article Versions
- Previous version (3 March 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.